Best Healthcare Companies in Switzerland
The 618 best Healthcare companies in Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Idorsia.
Switzerland's Healthcare sector, tracked across 618 companies and $2.7B in disclosed funding, is one of Europe's most capital-dense biotech corridors right now. Idorsia leads the directory by a wide margin at $1.2B raised, which tells you something about where the weight sits: drug development, not digital health. The global market hit roughly $2 trillion in 2020 and is forecast to climb toward $2.6 trillion by 2025 at a 6.3% CAGR, and strict compliance to product safety is the structural constraint that shapes every funding round here. The hot themes this quarter are vaccine candidates, vaccine trials, and immunogenicity data, which tracks with what I'm seeing across European biotech pipelines broadly.
Median app installs across healthcare verticals are up roughly 16% year-on-year, so the digital layer is moving even if Switzerland's funding story stays pharma-heavy. Swixx BioPharma sits at $55M, NextKidney at $20M, and Axmed at $18M, which rounds out the tier below Idorsia fast. As shown in 2017 research, care delivery preferences are shifting toward virtual touchpoints, and that pressure is starting to show up in where newer entrants are pitching. So if you're mapping the sector, watch the gap between the top funder and everyone else, because it's wide and it's deliberate.
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
Ranked: Best Healthcare companies in Switzerland
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Idorsia R&D company focused on manufacturing diversified drugs for multiple therapeutic areas | $1.2B | 8 mo ago | Public | 1,100 | — | 7 signals ▼79% Earnings · Leadership · IPO | — | — |
| 2 | Covis Pharma Pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and… | $350M | 90 mo ago | Acquired | 10 | Michael Porter CEO | — | — | — |
| 3 | Mediliant Medical device product design and development firm | $180M | 84 mo ago | Late Stage | 57 | Denis Leissing CEO | — | — | — |
| 4 | Galenica Manufacturer of pharma and OTC products | $156M | 135 mo ago | Public | 2,839 | Pascal Girardat Founder Lifestage Solutions Ag / Board Member Emeda Ag | 10 signals ▼23% M&A · Earnings · Board | — | 1 expansion |
| 5 | Spital Emmental Chain of multi-speciality hospitals | $130M | — | Funding Raised | 163 | Anton Schmid CEO | — | — | — |
| 6 | Rejuveron Life Sciences Developer of drugs for treating age related diseases | $76M | 33 mo ago | Series B | 18 | Marc Ramis Castelltort Co-Founder | — | — | — |
| 7 | Swixx BioPharma Provider of sales, funding management and other finance related services catering to Biopharma sector | $55M | 6 mo ago | Series C | 1,200 | Petr Nemec Co-Founder & Board Member | 3 signals ▲200% M&A · Funding | — | 8 job openings · 2 awards |
| 8 | Genkyotex Small molecule therapeutics that selectively inhibit NOX enzymes | $52M | 93 mo ago | Acquired | 11 | — | — | 151 patents Small-molecule NADPH oxidase inhibitor drugs for treating oxidative stress diseases | — |
| 9 | Cimeio Therapeutics Provider of hematopoietic stem cell transplant and adoptive cell therapy services | $50M | 50 mo ago | Series A | 29 | Thomas Fuchs Chief Executive Officer | — | 37 patents Antibody therapeutics targeting CD33, CD117, and CD45 for hematologic cell therapies | — |
| 10 | SwissSmile Chain of dental care clinics | $47M | 154 mo ago | Series B | 48 | Jürg Trepp CEO | — | — | — |
| 11 | Keri Medical Develops and manufactures a range of medical devices for hand and wrist surgery | $43M | 39 mo ago | Acquired | 70 | — | 3 signals M&A · FDA approval | 16 patents Patents concentrated in health & consumer products | 1 launch |
| 12 | Telormedix Biopharma company focused on evaluating and establishing role of innate immunity in treating cancer and… | $34M | 150 mo ago | Deadpooled | 7 | — | — | 56 patents Topical imidazoquinoline immune agonists and phospholipid‑based drug delivery formulations. | — |
| 13 | Endogena Therapeutics Discovering and developing endogenous regenerative medicines | $29M | 54 mo ago | Series A | 16 | — | — | — | — |
| 14 | Vicarius Pharma Provider of market access & HEOR consulting services | $22M | 106 mo ago | Deadpooled | 3 | Hans Hasler CEO & President | — | — | — |
| 15 | Medimaps Group Developer of AI-powered bone health assessment software | $20M | 54 mo ago | Series B | — | Didier Hans CEO & President | — | 33 patents AI-driven texture analysis of medical imaging for tissue and bone diagnostics | — |
| 16 | NextKidney Manufacturer of home hemodialysis device | $20M | 15 mo ago | Series B | 25 | Jerome Augustin CEO | — | 43 patents Patents concentrated in health & consumer products | 1 job opening |
| 17 | zahnarztzentrum.ch Chain of dental care clinics | $19M | 189 mo ago | Acquired | 700 | Sara Hürlimann Co-Founder | — | — | — |
| 18 | Axmed Platform connecting healthcare providers with prequalified medicine manufacturers in low- and middle-income… | $18M | 3 mo ago | Seed | — | Sofía Radley-Searle Co-Founder & COO | — | — | 1 partnership · 1 award |
| 19 | Nemis Technologies Developer of diagnostic kits for microbiological detection | $15M | 52 mo ago | Series A | 17 | — | — | — | — |
| 20 | Hedera Dx Provider of cancer testing services | $14M | 12 mo ago | Series A | 22 | Damien Lapray Co-Founder | — | — | — |
| 21 | CCX Provider of gene therapy, pricing, and therapeutics development services | $12M | 35 mo ago | Series A | 25 | Nathan Sigworth Co-Founder & CEO | — | — | — |
| 22 | Develco Pharma Development of APIs and controlled release solid dosage forms | $11M | 20 mo ago | Series A | 130 | — | — | 68 patents Controlled-release oral dosage forms and depression therapeutics using hydroxynorketamine. | 1 award |
| 23 | Alpex Pharma CRO company offers services for pharmaceutical companies | $9M | 225 mo ago | Series B | 50 | Shahbaz Ardalan CEO & MD | — | 113 patents Oral solid dosage formulations: extended‑release, orodispersible, and granular drug delivery systems. | — |
| 24 | HAIR & SKIN Chain of skin and hair clinics | $9M | 43 mo ago | Series B | 243 | Omar Haroon Md Co-Founder | — | — | — |
| 25 | Roger Provider of healthcare technology services | $8M | 22 mo ago | Seed | 3 | Victor Charlier Managing Director | — | — | — |
| 26 | Kinarus R&D company focused on manufacturing of drugs for multiple therapeutic areas | $8M | 45 mo ago | Public | 9 | — | — | 22 patents Ophthalmic drug formulations and combination therapies for viral and fibrotic diseases | — |
| 27 | Loop medical Provider of needle-free blood collection technology | $7M | 56 mo ago | Series A | 22 | — | — | 27 patents Integrated point‑of‑care fluid sampling devices with trigger and electronic modules | — |
| 28 | Acthera Therapeutics Provider of research, development, and manufacturing services for small molecule drugs | $6M | 59 mo ago | Seed | 10 | Andreas Zumbuhl Co-Founder | — | — | — |
| 29 | SYRHA Tech Providing management consulting services to medical device manufacturers | $5M | 12 mo ago | Series A | 10 | Gilles Bos Founder | — | — | — |
| 30 | CARBOGEN AMCIS CDMO specializing in highly potent APIs | $4M | 57 mo ago | Acquired | 1,001 | Pascal Villemagne Group CEO | 3 signals ▲50% Announcements · Leadership · Funding | 12 patents Synthesis of psilocybin derivatives and hydroxy‑vitamin D analogs for therapeutic use | — |
| 31 | Bottneuro Provider of neuromodulation therapies for people suffering from alzheimer's disease | $4M | 42 mo ago | Series A | 11 | Bekim Osmani CEO & Co-Founder at Bottneuro AG | — | 15 patents Patents concentrated in health & consumer products | — |
| 32 | AERA Health Provider of testing, team training, support, and coaching services | $4M | 38 mo ago | Seed | — | Andrea Gartenbach Co-Founder | — | — | — |
| 33 | Malcisbo Develops novel carbohydrate-based vaccines for human & animal health | $4M | 176 mo ago | Seed | 6 | — | — | 8 patents Engineered bacterial-based vaccine platforms for glyco-modified antigens. | — |
| 34 | Rivia Develops tool for drug clinical trials | $3M | 24 mo ago | Seed | — | — | — | — | 1 award |
| 35 | BIONTER CRO providing bio analytical services | $3M | 49 mo ago | Seed | 5 | Tobias Werk CEO | — | 13 patents Disposable diagnostic containers and liquid sample testing devices for point‑of‑care analysis | — |
| 36 | Hemaxis Developer of microfluidic devices for micro blood sampling | $3M | 81 mo ago | Series A | 6 | — | — | — | — |
| 37 | FluoSphera CRO focused on providing drug development services for biopharma sector | $2M | 5 mo ago | Seed | 3 | Aurélien Roux Co-Founder | — | — | 1 partnership |
| 38 | Metaphysiks Lab focused on manufacturing of tech products for skin diseases treatment | $2M | 47 mo ago | Seed | 6 | Olaf Blanke Co-Founder | — | — | — |
| 39 | HemostOD Developer of solutions to produce ex vivo platelets | $2M | 57 mo ago | Seed | 8 | Faouzi Khechana Co-Founder & CEO | — | 14 patents Patents concentrated in chemistry & materials | — |
| 40 | HEMEX Provider of regulatory affairs, marketing, and other services for healthcare sector | $1M | 42 mo ago | Funding Raised | 22 | Pascal Winnen Founder | — | — | 2 partnerships |
| 41 | DAAV AI-powered robotic wheelchairs for inclusive airport travel | $1M | 24 mo ago | Seed | 6 | — | — | — | — |
| 42 | HMCARE Manufacturer of face masks | $1M | 72 mo ago | Seed | 4 | Diane Baatard Co-Founder | — | — | — |
| 43 | Zynnon Provider of AI-powered non-contact thermometers | $835K | 47 mo ago | Seed | — | Khaled Abousaleh CEO | — | 11 patents Real-time airborne pathogen detection using gas‑phase biomarker sensor technology | — |
| 44 | Doppl Provider of clinical research, drugs development, and compounding services | $576K | 28 mo ago | Funding Raised | — | Nathalie Brandenberg Founder & CEO | — | — | — |
| 45 | aiEndoscopic Manufacturer of endoscopy devices | $568K | 38 mo ago | Seed | 5 | Philippe Ganz Co-Founder & CEO | — | 4 patents Advanced airway intubation devices and kits for precise tracheal tube placement | 2 internships · 1 partnership |
| 46 | LS Instruments Manufacturer of instruments for use in R&D of biopharmaceuticals, cosmetics, food and inks | $447K | 54 mo ago | Seed | — | Dario Leumann CEO | — | — | — |
| 47 | Aquilo Sports Manufacturer of cold and compression therapy sports recovery systems | $351K | 49 mo ago | Funding Raised | — | — | — | — | — |
| 48 | Bioscibex Biotechnology company developing single-use bioreactors for bioproduction | $188K | 8 mo ago | Seed | — | Francois Carruzzo Co-Founder & CTO | — | — | — |
| 49 | Calico Biosystems Provider of research services and drugs for cancer patients | $167K | 23 mo ago | Seed | — | Riccardo Turrini Co-Founder | — | — | 2 awards |
| 50 | HeroSupport Provider of personalise medical treatment services for patients comforts | $114K | 27 mo ago | Seed | 4 | Giovanna Dipasquale Chief Executive Officer | — | — | — |
Top 12 Healthcare companies in Switzerland
#1
Public · Allschwil, Basel Landschaft · founded 2017 · 1100 employees$1.2Braised▾
R&D company focused on manufacturing diversified drugs for multiple therapeutic areas
- Oct 2025Post IPO$81.6M
- Jul 2021Post IPO$655.4M
- Jun 2018Post IPO$508.4M
- Feb 2018Post IPO—
#2
Series C · Baar, Canton of Zug · founded 2013 · 1200 employees$54.9Mraised▾
Provider of sales, funding management and other finance related services catering to Biopharma sector
- Dec 2025PE—
- May 2021Series C$54.9M
- 2017Seed—
#3
Seed · Basel, Basel City · founded 2023$18Mraised▾
Platform connecting healthcare providers with prequalified medicine manufacturers in low- and middle-income countries. It operates a marketplace that facilitates the sourcing and supply of medicines. The company also provides advisory services to pharmaceutical companies, assisting them in expanding their presence in low- and middle-income countries by developing access strategies. The aim is to improve patient access to quality and affordable medicines.
- Feb 2026Grant (prize money)$6M
- May 2025Grant (prize money)$5M
- May 2024Seed$2M
- Grant (prize money)$5M
#4
Seed · Geneva, Geneva · founded 2020 · 3 employees$2Mraised▾
CRO focused on providing drug development services for biopharma sector
- Jan 2026Seed$1.4M
- Mar 2023Seed$1M
- Dec 2022Seed$1M
- Aug 2021Grant (prize money)$54.6K
#5
Series A · Epalinges, Vaud · founded 2021 · 22 employees$14Mraised▾
Provider of cancer testing services
#6
Series B · Lausanne, Vaud · founded 2020 · 25 employees$20Mraised▾
Manufacturer of home hemodialysis device
- Feb 2025Grant (prize money)$2.6M
- Jan 2023Series B$12.8M
- Jul 2021Angel$7.1M
#7
Series A · Plan les Ouates, Geneva · founded 2018 · 10 employees$5.5Mraised▾
Developer of injectable medical devices designed for medical applications. The company makes visco-elastic alternatives for aesthetic dermatology, orthopedics, and ophthalmology and offers CDMO (contract development and manufacturing organization) activities with a high level of performance, quality, and competence. enabling clients to formulate their customized products using technological and scientific formulation assistance.
- May 2025Series A$5.5M
#8
Series A · Pratteln, Basel Landschaft · founded 2006 · 130 employees$11Mraised▾
Develco Pharma is focussed on providing contract manufacturing services for API and controlled release solid dosage forms. Its services include sourcing and development of APIs, project management from evaluation through all stages of project execution, analytical services to support the pharmaceutical development process, clinical development and advise in the design and monitoring of clinical and registration. The company's product portfolio has 6 products which have been approved in Europe and 1 in the US.
#9
Seed · Wallisellen, Zurich · founded 2021 · 3 employees$7.6Mraised▾
Developer of medical software designed for digitizing and optimizing the practice management of dentists. The company's platform acts as a virtual employee that helps dental practices to keep an overview of patients and their treatment plans in a timely manner, enabling dentists to demonstrably increase their sales through the gain inefficiency.
- Aug 2024Seed$7.6M
#10
Seed · Monthey, Valais · founded 2024$188.2Kraised▾
Biotechnology company developing single-use bioreactors for bioproduction. The company develops all-in-one single-use bioreactors for cell culture and biologic drug production. The company's technology enables integrated cell culture system, allowing bioproduction.
- Sep 2025Seed$188.2K
#11
Series B · Zug, Canton of Zug · founded 2019 · 18 employees$76.3Mraised▾
Developer of drugs for treating age-related diseases. The company has developed drugs and technologies which aim to treat cures for age-related diseases for healthier lives.
- Sep 2023Series B$75M
- Mar 2021Seed$1.3M
#12
Acquired · Geneva, Geneva · founded 2017 · 70 employees$43.3Mraised▾
Develops and manufactures a range of medical devices for hand and wrist surgery
- Mar 2023Series C$32.3M
- Nov 2020Series B$11M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.